Subex Q1 FY27 earnings call

Subex reported a robust Q1 FY27, with revenue reaching INR 79.45 crores, marking an 8.9% sequential growth and a significant 19.7% year-over-year increase. The company achieved an EBITDA margin of 21.2%, with EBITDA growing fourfold compared to the same quarter last year. PAT stood at 17.9%, reflecting improved profitability. The quarter closed with a healthy cash and cash equivalents balance of INR 184.8 crores, strengthening the balance sheet and providing flexibility for future investments.

Management emphasized that FY27 marks the beginning of a new phase focused on accelerating consistent and sustainable growth, moving beyond the turnaround phase. Key growth drivers include continued investment in product innovation, enhancing AI capabilities, strengthening customer-facing teams, and ensuring delivery excellence. The company aims for double-digit or high single-digit revenue growth for the fiscal year, with a particular focus on expanding its Partner Ecosystem Management (PEM) product, which is now seeing stronger deal flow.

The company has instilled greater operational discipline, leading to improved execution of its order backlog and consistent achievement of key billing milestones. Tighter cost management has also contributed to the strong margin performance. While pleased with the current profitability, management stated that the objective is not to maximize short-term margins but to maintain a healthy margin structure (around the current 21.2% EBITDA margin) while making disciplined investments to create greater long-term shareholder value.

Subex maintains a qualified deal pipeline that is typically 3-4 times its annual order intake target, providing good visibility. Approximately 70% of the company's revenue is recurring, offering a stable base. Recent wins include the renewal of managed services and software license agreements with a Tier 1 Middle East operator, new business assurance and fraud management deals in Europe, and a PEM engagement renewal in Asia-Pacific. These wins demonstrate customer confidence and market presence, despite not announcing every deal.

The Board has approved an ESOP plan to acquire up to 5% of shares from the market, with a plan to execute 2% of this in Q3 FY27, aligning management and employee incentives. The company is also strongly considering a capital readjustment to reduce equity capital by writing off past losses, a long-term process requiring consultant appointment and regulatory approvals. With INR 184.8 crores in cash, Subex is actively exploring inorganic growth opportunities, though no specific M&A targets are currently being pursued.

Subex's R&D strategy is structured across three horizons: H1 focuses on making current products (RAFM, PEM) fully GenAI-enabled and world-class. H2 aims at expanding into exciting new markets like data centers and satellites, leveraging CapEx expansion trends. H3 involves highly experimental bets on tackling complex, evolving fraud types such as social engineering and account takeover. R&D intensity is expected to increase, with a strategic allocation of 60% to H1, 30% to H2, and 10% to H3, reflecting a commitment to innovation and future growth.

Management acknowledged a slowdown in the Middle East market, primarily due to geopolitical factors, leading to delays of 1-2 months in contract closures. Similar extended timelines are also being observed in the APAC region. While no contracts have been cancelled, the legal and commercial negotiation processes are taking longer than anticipated. As a mitigation strategy, Subex has offshored delivery to India for Middle East projects to ensure continuity, and the Middle East subsidiary remains self-sufficient without requiring further capital infusion.